Tavo sveikatos namai, UAB - financials and debts

Company age: 15 y. 5 mo.

Update

Tavo sveikatos namai - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 552,441 714,277 801,989 856,608 795,784 950,685 1,120,054 1,035,620
Profit before tax 47,257 14,486 15,869 66,202 32,520 -14,128 64,577 14,154
Net profit 41,860 12,826 13,968 58,474 28,999 -14,128 60,275 11,752
Equity 132,096 144,922 158,890 217,364 246,363 132,235 192,510 104,262
Liabilities 78,274 125,337 169,150 190,317 146,175 166,133 207,832 88,757
Non-current assets 26,573 18,621 9,665 4,292 15,790 37,736 30,324 21,059
Current assets 183,055 247,733 318,375 403,389 375,354 255,833 369,602 169,091
Total assets 209,628 266,354 328,040 407,681 391,144 293,569 399,926 190,150
Taxes paid
STI taxes - - - - - 145,364 130,475 175,593
Social insurance contributions - - - - - 131,295 145,883 157,860
Financial indicators
Revenue change y/y +16.4% +29.3% +12.3% +6.8% -7.1% +19.5% +17.8% -7.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 20.0% 4.8% 4.3% 14.3% 7.4% -4.8% 15.1% 6.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 31.7% 8.9% 8.8% 26.9% 11.8% -10.7% 31.3% 11.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 7.6% 1.8% 1.7% 6.8% 3.6% -1.5% 5.4% 1.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 8.6% 2.0% 2.0% 7.7% 4.1% -1.5% 5.8% 1.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.6 0.9 1.1 0.9 0.6 1.3 1.1 0.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 24,195 35,273 39,768 39,842 34,599 40,029 42,805 41,150

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Tavo sveikatos namai - Social security debts

From To Debt, €
2025-11-18 2025-11-18 12676.24
2025-04-24 2025-04-29 23.83
2025-03-18 2025-03-19 13303.88
2025-01-16 2025-01-21 6903.97
2024-10-24 2024-11-07 28.79
2024-07-16 2024-07-21 12572.61
2024-04-23 2024-04-28 47.11
2024-02-19 2024-02-26 13090.98
2023-02-17 2023-02-20 0.08
2022-04-25 2022-04-27 19.93
2022-01-26 2022-01-26 7062.22
2022-01-18 2022-01-25 6643.62
2021-12-06 2021-12-06 0.05
2021-11-16 2021-11-24 8.17

Tavo sveikatos namai - VMI tax arrears

From To Overdue, €
2026-06-30 2026-06-30 232.69
2026-06-19 2026-06-29 230.85
2026-04-11 2026-04-11 296.01
2026-04-08 2026-04-10 12342.95
2026-01-20 2026-01-31 147.21
2026-01-15 2026-01-19 20440.22
2025-10-30 2025-11-02 58.42
2025-10-18 2025-10-29 274.99
2025-09-25 2025-09-29 70.18
2025-09-17 2025-09-24 557.45
2025-08-19 2025-08-19 2470.26
2025-08-17 2025-08-18 17265.06
2025-05-31 2025-05-31 1158.11
2025-05-28 2025-05-30 1146.02
2025-03-22 2025-04-17 0.02
2025-03-19 2025-03-21 2091.8
2025-02-20 2025-03-18 0.02
2025-02-07 2025-02-10 18.92
2025-02-02 2025-02-06 189.83
2025-01-23 2025-02-01 183.24
2025-01-22 2025-01-22 24588.69
2024-12-13 2024-12-18 203.29
2024-11-20 2024-12-12 0.38
2024-11-17 2024-11-19 0.58
2024-10-14 2024-10-15 57.82

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Tavo sveikatos namai, UAB (code 302617035) is a Private Limited Liability Company active in medical specialists activities. In 2025, the company generated revenue of €1.04M and net profit of €11.8K, with a profit margin of 1.1%. Revenue decreased by 7.5% year on year, although it remained above the 2023 level; over two years, revenue increased by 8.9% compared with 2023. The profitability profile was more volatile: the company posted a net loss of €14.1K in 2023, improved strongly to net profit of €60.3K in 2024, and then returned to a smaller profit in 2025. At year-end 2025, total assets were €190.2K, equity €104.3K and liabilities €88.8K. Key balance sheet ratios show an equity ratio of 54.8% and debt-to-equity of 0.85. Efficiency indicators were also solid, with asset turnover at 5.45x, return on equity at 11.3% and return on assets at 6.2%. Revenue per employee was €41.4K, while profit per employee was €470.